XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Apr. 30, 2023 $ 37,409 $ 7,084 $ 5,059 $ (53) $ 28,761 $ (3,442)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 2,474       2,474  
Other comprehensive loss (144)         (144)
Stock-based compensation (309) 185 (494)      
Ending balance at Jul. 31, 2023 39,430 7,269 4,565 (53) 31,235 (3,586)
Beginning balance at Apr. 30, 2024 54,760 7,273 5,406 (2,051) 47,514 (3,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 2,193       2,193  
Other comprehensive loss (116)         (116)
Stock-based compensation (814) 80 (894)      
Ending balance at Jul. 31, 2024 $ 56,023 $ 7,353 $ 4,512 $ (2,051) $ 49,707 $ (3,498)